TABLE 3.
Test1: change from pre to post within and between groups |
||||||
Within groups |
Between groups |
|||||
EUM (n = 16) |
FHA (n = 14) |
|||||
p-Value | p-Value | p-Value | ||||
Prolactin (μg/L) | 68.6 ± 34.1 | 0.044 | 108.2 ± 35.7 | 0.002 | −39.7 ± 49.1 | 0.419 |
ACTH (μg/L) | 65.9 ± 12.4 | <0.001 | 68.7 ± 12.5 | <0.001 | 2.8 ± 17.6 | 0.874 |
Cortisol (nmol/L) | 7.6 ± 37.5 | 0.838 | 79.5 ± 38.9 | 0.041 | −71.8 ± 53.9 | 0.183 |
GH (μg/L) | 3.7 ± 2.1 | 0.077 | 4.1 ± 2.1 | 0.049 | −0.4 ± 2.9 | 0.881 |
IGF-1 (μg/L) | 32.8 ± 4.3 | <0.001 | 36.5 ± 4.3 | <0.001 | −3.7 ± 6.1 | 0.545 |
IGFBP-3 (μg/L) | 0.9 ± 0.5 | 0.090 | 0.7 ± 0.5 | 0.218 | 0.2 ± 0.8 | 0.743 |
Insulin (pmol/L) | −58.3 ± 14.2 | <0.001 | −62.5 ± 14.2 | <0.001 | 4.2 ± 20.0 | 0.833 |
Prolactin:cortisol | 0.27 ± 0.15 | 0.061 | 0.16 ± 0.152 | 0.278 | 01.1 ± 0.21 | 0.605 |
Cortisol:insulin | 0.007 ± 0.003 | 0.011 | 0.009 ± 0.003 | 0.001 | −0.002 ± 0.004 | 0.605 |
GH:cortisol | 0.010 ± 0.010 | 0.338 | 0.003 ± 0.01 | 0.757 | 0.006 ± 0.014 | 0.659 |
GH:insulin | 0.852 ± 1.39 | 0.540 | 0.985 ± 1.39 | 0.479 | −0.133 ± 1.966 | 0.946 |
IGF-1:IGFBP-3 | −0.88 ± 1.17 | 0.452 | 0.11 ± 1.17 | 0.922 | −0.99 ± 1.65 | 0.548 |
IGF:cortisol | 0.187 ± 0.093 | 0.045 | 0.014 ± 0.097 | 0.884 | 0.173 ± 0.134 | 0.198 |
BDNF (μg/L) | 3.6 ± 22.9 | 0.875 | 41.9 ± 23.5 | 0.074 | −38.3 ± 32.8 | 0.243 |
Data shown as mean and standard error. EUM, eumenorrheic athletes; athletes with FHA, functional hypothalamic amenorrhea; ACTH, adrenocorticotropic hormone; BDNF, brain derived neurotrophic factor; GH, growth hormone; IGF-1, insulin like growth factor 1; IGFBP-3, insulin like growth factor binding protein 3.